fda glp-1 compounding warning september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Beyond the Headlines: FDA Warning

That's where B12 injections come in

This can lead to direct damage to cellular organelles including mitochondria

It's about building good lab habits that respect the science and the investment you've made in your research materials

Importantly, GLP-1 has substantial local effects in the lamina propria before reaching systemic circulation as a result of rapid degradation by DPP-4 enzyme

Knockdown of IREB2 reduces ferroptosis susceptibility ( 3.1.4 Redox stress-metabolic pathways regulating ferroptosis Additional regulators of ferroptosis include coenzyme Q10 (CoQ10), NADPH, selenium, p53, NRF2/NFE2L2, and vitamin E

Total loss approaching 20% by month 6